Tumor xenografts expressing INPP5A shRNAs displayed reduced mRNA levels and significant tumor growth inhibition compared to those harboring a control shRNA (Fig. 6a,b and Extended Data Fig. 9a). The gene discussed is INPP5A; the disease is neoplasm.